Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring
Lauren E Colbert,Molly B El Alam,Rui Wang,Tatiana Karpinets,David Lo,Erica J Lynn,Timothy A Harris,Jacob H Elnaggar,Kyoko Yoshida-Court,Katarina Tomasic,Julianna K Bronk,Julie Sammouri,Ananta V Yanamandra,Adilene V Olvera,Lily G Carlin,Travis Sims,Andrea Y Delgado Medrano,Tatiana Cisneros Napravnik,Madison O'Hara,Daniel Lin,Chike O Abana,Hannah X Li,Patricia J Eifel,Anuja Jhingran,Melissa Joyner,Lilie Lin,Lois M Ramondetta,Andrew M Futreal,Kathleen M Schmeler,Geena Mathew,Stephanie Dorta-Estremera,Jianhua Zhang,Xiaogang Wu,Nadim J Ajami,Matthew Wong,Cullen Taniguchi,Joseph F Petrosino,K Jagannadha Sastry,Pablo C Okhuysen,Sara A Martinez,Lin Tan,Iqbal Mahmud,Philip L Lorenzi,Jennifer A Wargo,Ann H Klopp
DOI: https://doi.org/10.1016/j.ccell.2023.09.012
IF: 50.3
2023-11-13
Cancer Cell
Abstract:Tumor microbiota can produce active metabolites that affect cancer and immune cell signaling, metabolism, and proliferation. Here, we explore tumor and gut microbiome features that affect chemoradiation response in patients with cervical cancer using a combined approach of deep microbiome sequencing, targeted bacterial culture, and in vitro assays. We identify that an obligate L-lactate-producing lactic acid bacterium found in tumors, Lactobacillus iners, is associated with decreased survival in patients, induces chemotherapy and radiation resistance in cervical cancer cells, and leads to metabolic rewiring, or alterations in multiple metabolic pathways, in tumors. Genomically similar L-lactate-producing lactic acid bacteria commensal to other body sites are also significantly associated with survival in colorectal, lung, head and neck, and skin cancers. Our findings demonstrate that lactic acid bacteria in the tumor microenvironment can alter tumor metabolism and lactate signaling pathways, causing therapeutic resistance. Lactic acid bacteria could be promising therapeutic targets across cancer types.